Neil Versel

In a recent paper, GTC and its partners validated their RNAnalysis and TraceWork algorithms for targeted transcriptome and clinical decision support.

The companies have expanded their partnership to include GE's Fabric technology as they seek to predict response to metastatic non-small cell lung cancer therapies.

Tempus hopes to get the right patients into genetic sequencing, targeted therapies, and clinical trials with its Edge AI platform and NAPA digital pathology data network.

Genetic oncologist and informatician Olufunmilayo Olopade called for greater diversification of genomic datasets to inform early interventions in high-risk communities.

The bioinformatics firm hopes its AI and "NASA-style" command center will make it easier to get cancer patients into NGS labs and improve trial matching.

Philips has automated the informatics pipeline for NYU Langone's pan-cancer LDT and integrated its Genomics Workspace software with the health system's Epic EMR.

The new partners seek to close the information loop by including providers, payors, and patients in biomarker-guided cancer therapy decisions.

In a keynote to the AMIA Informatics Summit, the NCI director said precision oncology has created new challenges in data analysis and management.

With a new $16 million NCI grant, Count Me In is working with the Broad and Dana-Farber to engage osteosarcoma and leiomyosarcoma patients in their own care and in research.

With nearly $100 million in new investments since last year, the San Francisco-based informatics firm looks to ramp up its precision oncology partnerships.